SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page1234567Next Page
2026-09-17ELVN144Hohl Benjamin plan to sell securities of Enliven Therapeutics, Inc. under Form 144MEDIUM
Hohl Benjamin filed Form 144 to notify SEC of plan to sell 12036 units of Enliven Therapeutics, Inc. securities around 2026-09-17, with aggregate market value of $591,208.32. The total outstanding units is 73000000.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in past...
Mid CapBiotechnology
Previous Page1234567Next Page